Ventricular septal defect medical therapy
|
Ventricular septal defect Microchapters | |
|
Differentiating Ventricular Septal Defect from other Diseases | |
|---|---|
|
Diagnosis | |
|
ACC/AHA Guidelines for Surgical and Catheter Intervention Follow-Up | |
|
Case Studies | |
|
Ventricular septal defect medical therapy On the Web | |
|
American Roentgen Ray Society Images of Ventricular septal defect medical therapy | |
|
Risk calculators and risk factors for Ventricular septal defect medical therapy | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [[2]]; Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]
Overview
ACC/AHA 2008 Guidelines: Recommendation for Medical Therapy - Ventricular Septal Defect[1](DO NOT EDIT)
| Class IIb |
| "1. Pulmonary vasodilator therapy may be considered for adults with VSDs with progressive/severe pulmonary vascular disease (refer to the National Guideline Clearinghouse [NGC] summary of the ACC/AHA guideline, Pulmonary Hypertension/Eisenmenger Physiology).(Level of Evidence: B) " |
References
- ↑ Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.